RISPERDAL Safety Questions, RISPERDAL Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about RISPERDAL. Our extensive database of RISPERDAL adverse events and RISPERDAL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about RISPERDAL

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




RISPERDAL Safety Reports

Total RISPERDAL reports: 1254.
RISPERDAL FDA safety alerts: 2003 2004 .
Reported deaths: 176    Reported hospitalizations: 481.
Take RISPERDAL Side Effects Survey or Share Your RISPERDAL Story. RISPERDAL Usage.

Showing 1-75 of 1254 Next >

Health Professional from UNITED KINGDOM reported RISPERDAL problem on Jan 25, 2007. Male patient, 26 years of age, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, psychotic disorder, suicidal ideation. RISPERDAL dosage: 4-5 MG. During the same period patient was treated with OLANZAPINE, VALPROATE. Patient recovered.

RISPERDAL problem was reported by a Physician from JAPAN on Jan 30, 2007. Female patient, weighting 220.5 lb, was diagnosed with schizophrenia and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: aspiration, cardio-respiratory arrest, diabetes mellitus, diabetic ketoacidosis, gastrointestinal haemorrhage, refusal of treatment by patient, water intoxication. RISPERDAL dosage: unknown. During the same period patient was treated with SEROQUEL, ARTANE. Patient died on 04/18/2004.

Health Professional from FRANCE reported RISPERDAL problem on Jan 26, 2007. Male patient, weighting 154.3 lb, was diagnosed with aggression and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome. RISPERDAL dosage: unknown. During the same period patient was treated with DEPAKENE, TERCIAN, SOLIAN, PARKINANE LP. Patient was hospitalized. Patient recovered.

RISPERDAL problem was reported by a Physician from GERMANY on Jan 29, 2007. Female patient, weighting 165.3 lb, was diagnosed with borderline personality disorder and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: multiple sclerosis. RISPERDAL dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported RISPERDAL problem on Jan 29, 2007. Female patient, 45 years of age, weighting 220.5 lb, was diagnosed with psychotic disorder and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: chest pain, myocarditis. RISPERDAL dosage: unknown. During the same period patient was treated with CLOPIXOL. Patient died on 10/30/2005.

RISPERDAL problem was reported by a Physician from UNITED KINGDOM on Jan 26, 2007. Male patient, weighting 233.7 lb, was diagnosed with bipolar disorder and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: congestive cardiomyopathy. RISPERDAL dosage: unknown. During the same period patient was treated with ECSTASY, CANNABIS. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported RISPERDAL problem on Jan 29, 2007. Female patient, 80 years of age, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: agranulocytosis. RISPERDAL dosage: unknown. During the same period patient was treated with CHONDROSULF, LOVENOX, ARICEPT, DEXTRARINE PHENYLBUTAZONE, ACUPAN, ZOFRAN, SUFENTA. Patient was hospitalized. Patient recovered.

RISPERDAL problem was reported by a Physician from FRANCE on Jan 30, 2007. Male patient, 35 years of age, weighting 143.3 lb, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: leukopenia, neutropenia. RISPERDAL dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported RISPERDAL problem on Feb 01, 2007. Female patient, weighting 149.9 lb, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: electrocardiogram qt prolonged, suicide attempt, tachycardia. RISPERDAL dosage: unknown. During the same period patient was treated with ALCOHOL, PERAZIN, ZYPREXA. Patient recovered.

RISPERDAL problem was reported by a Physician from FRANCE on Jan 31, 2007. Female patient, 30 years of age, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: paralysis. RISPERDAL dosage: unknown. Patient recovered.

Physician from TURKEY reported RISPERDAL problem on Jan 31, 2007. Female patient, 54 years of age, weighting 149.9 lb, was diagnosed with schizoaffective disorder, hypothyroidism and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: dysphoria, parkinsonism. RISPERDAL dosage: unknown. During the same period patient was treated with VALPROATE, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

RISPERDAL problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 29, 2007. Male patient, 42 years of age, was diagnosed with schizophrenia and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: abasia, abnormal behaviour, aggression, constipation, depression, drooling, dysstasia, fall, fatigue. RISPERDAL dosage: unknown. During the same period patient was treated with CLOZARIL, HALDOL, COGENTIN, DEPAKOTE. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported RISPERDAL problem on Jan 31, 2007. Male patient, weighting 147.7 lb, was diagnosed with schizophrenia, paranoid type and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: psychotic disorder. RISPERDAL dosage: unknown. During the same period patient was treated with NEXIUM. Patient was hospitalized. Patient recovered.

RISPERDAL problem was reported by a Health Professional from GERMANY on Jan 31, 2007. Female patient, 70 years of age, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: somnolence, suicide attempt. RISPERDAL dosage: unknown. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, DOLOMO, DOXEPIN, IBUPROFEN, TAVOR, VESICARE. Patient recovered.

Health Professional from UNITED STATES reported RISPERDAL problem on Feb 08, 2007. Male patient, weighting 210.0 lb, was diagnosed with disease recurrence, schizophrenia, paranoid type and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: cogwheel rigidity, glossoptosis, refusal of treatment by patient, tardive dyskinesia, treatment noncompliance. RISPERDAL dosage: 50 MG IM Q2WEEKS. Patient recovered.

RISPERDAL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2007. Male patient, 27 years of age, weighting 302.0 lb, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, blood triglycerides increased, cerebrovascular disorder, diabetes mellitus non-insulin-dependent, hypertension, myocardial infarction, myocardial ischaemia, prescribed overdose, weight increased. RISPERDAL dosage: 2 MG, DAILY (1/D). During the same period patient was treated with GEODON, DEPAKOTE, LOPRESSOR, VALIUM, PAXIL. Patient was hospitalized. Patient recovered.

Physician from UNITED KINGDOM reported RISPERDAL problem on Feb 02, 2007. Male patient, 22 years of age, was diagnosed with schizophrenia, agitation, extrapyramidal disorder and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: gynaecomastia, hyperprolactinaemia. RISPERDAL dosage: unknown. During the same period patient was treated with HALOPERIDOL, LORAZEPAM, PROCYCLIDINE HYDROCHLORIDE. Patient recovered.

RISPERDAL problem was reported by a Physician from GERMANY on Feb 02, 2007. Male patient, weighting 154.3 lb, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: crying, tachycardia. RISPERDAL dosage: unknown. During the same period patient was treated with REMERGIL, SOLIAN. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported RISPERDAL problem on Jan 30, 2007. Female patient, 80 years of age, was diagnosed with dementia and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: arrhythmia, cardiac failure, dizziness, extrapyramidal disorder, pneumonia, renal failure. RISPERDAL dosage: unknown. During the same period patient was treated with HALOPERIDOL, GRAMALIL, ARICEPT. Patient recovered.

RISPERDAL problem was reported by a Health Professional from CANADA on Jan 31, 2007. Male patient, weighting 194.0 lb, was diagnosed with affective disorder and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, fall, hypersensitivity, hyponatraemia, loss of consciousness, pruritus. RISPERDAL dosage: unknown. During the same period patient was treated with VALPROIC ACID, STELAZINE, DALMANE, XANAX, NOZINAN. Patient recovered.

Physician from JAPAN reported RISPERDAL problem on Feb 01, 2007. Female patient, weighting 220.5 lb, was diagnosed with schizophrenia and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: aspiration, diabetes mellitus, diabetic ketoacidosis, polydipsia. RISPERDAL dosage: unknown. During the same period patient was treated with SEROQUEL, ARTANE, LORAZEPAM, HIRNAMIN, KAMAG G, PURSENNID, CARBAMAZEPINE. Patient died on 04/18/2004.

RISPERDAL problem was reported by a Physician from FRANCE on Feb 01, 2007. Male patient, weighting 209.4 lb, was diagnosed with schizophrenia, psychotic disorder and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy. RISPERDAL dosage: unknown. During the same period patient was treated with CLOZAPINE, LOXAPAC. Patient recovered.

Health Professional from UKRAINE reported RISPERDAL problem on Feb 02, 2007. Male patient, 38 years of age, was diagnosed with schizophrenia and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: diet refusal. RISPERDAL dosage: unknown. Patient died on 01/22/2007.

RISPERDAL problem was reported by a Physician from SPAIN on Feb 01, 2007. Female patient, weighting 59.52 lb, was diagnosed with abnormal behaviour and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: eosinophilia, skin reaction. RISPERDAL dosage: unknown. Patient recovered.

Physician from GERMANY reported RISPERDAL problem on Feb 06, 2007. Male patient, child 9 years of age, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: benign intracranial hypertension, papilloedema. RISPERDAL dosage: unknown. During the same period patient was treated with AMPHETAMINE. Patient recovered.

RISPERDAL problem was reported by a Physician from GERMANY on Feb 04, 2007. Female patient, weighting 143.3 lb, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: intentional overdose, nystagmus, sopor, suicide attempt. RISPERDAL dosage: unknown. During the same period patient was treated with TRILEPTAL. Patient recovered.

Physician from GERMANY reported RISPERDAL problem on Feb 06, 2007. Female patient, weighting 143.3 lb, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: convulsion, intentional overdose, mydriasis, somnolence, suicide attempt. RISPERDAL dosage: unknown. During the same period patient was treated with ALCOHOL, TRAMADOL. Patient recovered.

RISPERDAL problem was reported by a Pharmacist from FRANCE on Feb 05, 2007. Male patient, 23 years of age, weighting 138.9 lb, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: muscle contracture, trismus. RISPERDAL dosage: unknown. Patient recovered.

Physician from SPAIN reported RISPERDAL problem on Feb 05, 2007. Male patient, 23 years of age, was diagnosed with schizophrenia, paranoid type and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: dyskinesia, leukopenia. RISPERDAL dosage: unknown. Patient recovered.

RISPERDAL problem was reported by a Pharmacist from SPAIN on Feb 05, 2007. Male patient, weighting 48.50 lb, was diagnosed with autism and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: hair metal test abnormal. RISPERDAL dosage: unknown. Patient recovered.

Physician from FRANCE reported RISPERDAL problem on Feb 07, 2007. Male patient, 20 years of age, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: pelvic venous thrombosis. RISPERDAL dosage: unknown. Patient recovered.

RISPERDAL problem was reported by a Physician from SWITZERLAND on Feb 07, 2007. Male patient, child 4 years of age, was diagnosed with attention deficit/hyperactivity disorder, autism and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: confusional state, diplopia, nervousness, stereotypy. RISPERDAL dosage: unknown. Patient recovered.

Physician from UNITED KINGDOM reported RISPERDAL problem on Feb 07, 2007. Female patient, 26 years of age, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: blood prolactin increased, psychotic disorder. RISPERDAL dosage: unknown. Patient recovered.

RISPERDAL problem was reported by a Health Professional from NETHERLANDS on Feb 08, 2007. Female patient, 31 years of age, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: facial palsy. RISPERDAL dosage: unknown. Patient recovered.

Health Professional from UNITED KINGDOM reported RISPERDAL problem on Feb 07, 2007. Male patient, 41 years of age, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: dysuria, oedema peripheral. RISPERDAL dosage: unknown. Patient recovered.

RISPERDAL problem was reported by a Physician from CANADA on Feb 05, 2007. Male patient, weighting 160.1 lb, was diagnosed with schizophrenia, psychotic disorder, social phobia and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: idiopathic thrombocytopenic purpura. RISPERDAL dosage: unknown. During the same period patient was treated with ATIVAN, CIPRALEX, ESCITALOPRAM OXALATE. Patient recovered.

Health Professional from FRANCE reported RISPERDAL problem on Feb 12, 2007. Male patient, 65 years of age, was diagnosed with oligodendroglioma and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: dermatitis bullous, toxic skin eruption. RISPERDAL dosage: unknown. During the same period patient was treated with LARGACTIL, DEPAMIDE. Patient was hospitalized. Patient recovered.

RISPERDAL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 14, 2007. Female patient, weighting 120.0 lb, was diagnosed with schizoaffective disorder and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: amenorrhoea, blood prolactin increased, weight increased. RISPERDAL dosage: 3MG 3 TIMES PER DAY PO. During the same period patient was treated with COGENTIN. Patient recovered.

Consumer or non-health professional from GERMANY reported RISPERDAL problem on Feb 09, 2007. Male patient, weighting 24.25 lb, was diagnosed with accidental exposure and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: accidental exposure, fatigue. RISPERDAL dosage: unknown. Patient was hospitalized. Patient recovered.

RISPERDAL problem was reported by a Physician from GERMANY on Feb 09, 2007. Male patient, child 9 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: benign intracranial hypertension, papilloedema. RISPERDAL dosage: unknown. During the same period patient was treated with AMPHETAMINE. Patient recovered.

Pharmacist from JAPAN reported RISPERDAL problem on Feb 08, 2007. Male patient, weighting 6.50 lb, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: apnoeic attack, feeding disorder neonatal. RISPERDAL dosage: unknown. During the same period patient was treated with HALOMONTH. Patient was hospitalized. Patient recovered.

RISPERDAL problem was reported by a Health Professional from UNITED KINGDOM on Feb 09, 2007. Male patient, 35 years of age, was diagnosed with schizoaffective disorder and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: communication disorder, dysarthria. RISPERDAL dosage: unknown. During the same period patient was treated with VALPROATE. Patient recovered.

Physician from FRANCE reported RISPERDAL problem on Feb 12, 2007. Female patient, weighting 110.2 lb, was diagnosed with depression, disturbance in social behaviour, delusion and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus. RISPERDAL dosage: unknown. During the same period patient was treated with HALDOL, DEPAKENE, EFFEXOR. Patient recovered.

RISPERDAL problem was reported by a Health Professional from UNITED STATES on Feb 14, 2007. Male patient, weighting 192.0 lb, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus insulin-dependent, weight increased. RISPERDAL dosage: unknown. During the same period patient was treated with STRATTERA, ZYRTEC, CONCERTA, PERIACTIN. Patient was hospitalized. Patient recovered.

Physician from UNITED KINGDOM reported RISPERDAL problem on Feb 12, 2007. Female patient, weighting 75.00 lb, was diagnosed with cognitive disorder, schizoaffective disorder, insomnia, constipation, pain, dry skin, hyperhidrosis and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, circulatory collapse, fatigue, hypothermia, sedation, skin induration. RISPERDAL dosage: 2.0 MG AT NIGHT AND 0.5 MG IN THE MORNING. During the same period patient was treated with ZOLPIDEM TARTRATE, FOLIC ACID, MOVICOL, PARACETAMOL, COAMILOFRUSE. Patient recovered.

RISPERDAL problem was reported by a Health Professional from FRANCE on Feb 14, 2007. Female patient, 55 years of age, was diagnosed with schizophrenia and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: dysphagia. RISPERDAL dosage: unknown. During the same period patient was treated with TERCIAN, IMOVANE, LEPTICUR, SERESTA, PAROXETINE. Patient died on 11/19/2006.

Consumer or non-health professional from UNITED STATES reported RISPERDAL problem on Feb 20, 2007. Female patient, weighting 170.0 lb, was diagnosed with psychotic disorder and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: faecal incontinence, urinary incontinence. RISPERDAL dosage: 6 MG 2X DAILY PO. Patient recovered.

RISPERDAL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Female patient, 47 years of age, weighting 138.0 lb, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: galactorrhoea. RISPERDAL dosage: unknown. Patient recovered.

Physician from AUSTRIA reported RISPERDAL problem on Feb 20, 2007. Male patient, 50 years of age, was diagnosed with schizophrenia, parkinsonism, insomnia, anxiety and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: glomerulonephritis. RISPERDAL dosage: unknown. During the same period patient was treated with CLOZAPINE, AKINETON, TEMESTA. Patient died on 01/01/2006.

RISPERDAL problem was reported by a Physician from IRELAND on Feb 13, 2007. Female patient, 73 years of age, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, hypertension, left ventricular failure, lower respiratory tract infection. RISPERDAL dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported RISPERDAL problem on Oct 13, 2006. Male patient, weighting 192.0 lb, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus insulin-dependent, weight increased. RISPERDAL dosage: unknown. During the same period patient was treated with STRATTERA, ZYRTEC, CONCERTA, PERIACTIN. Patient was hospitalized. Patient recovered.

RISPERDAL problem was reported by a Health Professional from UNITED STATES on Nov 13, 2006. Male patient, weighting 236.0 lb, was diagnosed with depression and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus non-insulin-dependent, iron deficiency anaemia. RISPERDAL dosage: unknown. During the same period patient was treated with ZYPREXA, ZOLOFT, ACCUPRIL, MICROZIDE, ATENOLOL, HYDROCHLOROTHIAZIDE. Patient recovered.

Physician from JAPAN reported RISPERDAL problem on Feb 13, 2007. Female patient, weighting 220.5 lb, was diagnosed with schizophrenia and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: aspiration, diabetes mellitus, diabetic ketoacidosis, polydipsia, thirst. RISPERDAL dosage: unknown. During the same period patient was treated with SEROQUEL, ARTANE, LORAZEPAM, HIRNAMIN, PURSENNID. Patient died on 04/18/2004.

RISPERDAL problem was reported by a Consumer or non-health professional from AUSTRALIA on Feb 14, 2007. Male patient, weighting 220.5 lb, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: hypertriglyceridaemia, prescribed overdose. RISPERDAL dosage: unknown. During the same period patient was treated with METFORMIN HYDROCHLORIDE, DIAZEPAM, RANITIDINE. Patient recovered.

Physician from FRANCE reported RISPERDAL problem on Feb 16, 2007. Male patient, 40 years of age, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: embolism, respiratory disorder. RISPERDAL dosage: unknown. Patient died.

RISPERDAL problem was reported by a Physician from UNITED KINGDOM on Feb 15, 2007. Female patient, 47 years of age, was diagnosed with mania, psychotic disorder, sedation and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: respiratory depression, speech disorder. RISPERDAL dosage: unknown. During the same period patient was treated with DIAZEPAM. Patient recovered.

Pharmacist from UNITED STATES reported RISPERDAL problem on Feb 22, 2007. Male patient, weighting 194.0 lb, was diagnosed with psychotic disorder and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, dystonia, impaired self-care, incontinence, tonic clonic movements, tremor. RISPERDAL dosage: unknown. Patient was hospitalized. Patient recovered.

RISPERDAL problem was reported by a Health Professional from UNITED STATES on Nov 15, 2006. Male patient, weighting 174.0 lb, was diagnosed with bipolar i disorder and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, blood triglycerides increased, diabetes mellitus insulin-dependent. RISPERDAL dosage: unknown. During the same period patient was treated with ZYPREXA. Patient recovered.

Health Professional from UNITED STATES reported RISPERDAL problem on Jan 24, 2007. Male patient, weighting 102.5 lb, was diagnosed with bipolar disorder and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus insulin-dependent, homicidal ideation, hypothyroidism, suicide attempt, weight increased. RISPERDAL dosage: unknown. During the same period patient was treated with ZYPREXA, COGENTIN, RITALIN. Patient was hospitalized. Patient recovered.

RISPERDAL problem was reported by a Physician from ISRAEL on Feb 27, 2007. Male patient, 42 years of age, was diagnosed with schizophrenia and was treated with RISPERDAL. RISPERDAL dosage: unknown. During the same period patient was treated with CLONEX, CLOPIXOL ACUPHASE, ENTUMIN, DEKINET. Patient died on 12/29/2006.

Physician from JAPAN reported RISPERDAL problem on Feb 15, 2007. Female patient, 48 years of age, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, depressed level of consciousness, peroneal nerve palsy, pneumonia aspiration, therapeutic agent toxicity. RISPERDAL dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE, BIPERIDEN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

RISPERDAL problem was reported by a Consumer or non-health professional from FRANCE on Feb 16, 2007. Female patient, 15 years of age, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: psychomotor hyperactivity. RISPERDAL dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported RISPERDAL problem on Jan 29, 2007. Female patient, weighting 134.0 lb, was diagnosed with schizophrenia and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: gastrooesophageal reflux disease, homicidal ideation, pancreatitis, self injurious behaviour, suicidal ideation. RISPERDAL dosage: unknown. During the same period patient was treated with ZYPREXA, LITHIUM CARBONATE, TRAZODONE, XANAX, REGLAN, PROTONIX. Patient was hospitalized. Patient recovered.

RISPERDAL problem was reported by a Health Professional from UNITED STATES on Feb 27, 2007. Female patient was diagnosed with paranoia, schizophrenia and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: accidental exposure, device breakage. RISPERDAL dosage: 25MG Q 2 WEEKS UNK. Patient was hospitalized and became disabled. Patient recovered.

Consumer or non-health professional from UNITED STATES reported RISPERDAL problem on Feb 28, 2007. Male patient, 57 years of age, weighting 140.0 lb, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: anger, depressed mood, diabetes mellitus, emotional disorder, extrasystoles, feeling abnormal, feeling guilty, hallucination, auditory, hemiparesis. RISPERDAL dosage: ? 1/2 MG -} 1 ONE/DAY. During the same period patient was treated with ATENOLOL. Patient recovered.

RISPERDAL problem was reported by a Physician from GERMANY on Feb 20, 2007. Male patient was diagnosed with psychotic disorder and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: venous thrombosis limb. RISPERDAL dosage: unknown. Patient recovered.

Physician from GERMANY reported RISPERDAL problem on Feb 21, 2007. Male patient, 62 years of age, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: glycosylated haemoglobin increased. RISPERDAL dosage: unknown. During the same period patient was treated with CYMBALTA. Patient recovered.

RISPERDAL problem was reported by a Pharmacist from JAPAN on Feb 19, 2007. Female patient, 30 years of age, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. RISPERDAL dosage: unknown. Patient recovered.

Health Professional from FRANCE reported RISPERDAL problem on Feb 20, 2007. Male patient, 30 years of age, was diagnosed with schizophrenia and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: cyanosis, neutrophilia, pyrexia, tachycardia. RISPERDAL dosage: unknown. During the same period patient was treated with DEPAKENE, LOXAPAC, CLOZAPINE PANPHARMA, TRAMADOL, AUGMENTIN, PARKINANE LP, SCOPODERM TTS, SEGLOR. Patient died on 11/22/2006.

RISPERDAL problem was reported by a Physician from JAPAN on Feb 21, 2007. Male patient, 34 years of age, was diagnosed with agitation and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: amphetamines positive. RISPERDAL dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported RISPERDAL problem on Feb 20, 2007. Female patient, 53 years of age, was diagnosed with delirium and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: aggression, encephalopathy, parkinsonism. RISPERDAL dosage: unknown. Patient recovered.

RISPERDAL problem was reported by a Physician from JAPAN on Feb 22, 2007. Male patient, 23 years of age, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: dry skin, metamyelocyte count increased. RISPERDAL dosage: unknown. During the same period patient was treated with VALERIN. Patient recovered.

Health Professional from UNITED KINGDOM reported RISPERDAL problem on Feb 22, 2007. Female patient, 81 years of age, was diagnosed with psychotic disorder and was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: eye oedema, face oedema, oedema peripheral. RISPERDAL dosage: unknown. Patient was hospitalized. Patient recovered.

RISPERDAL problem was reported by a Physician from ISRAEL on Feb 25, 2007. Male patient, 59 years of age, was diagnosed with schizophrenia, residual type and was treated with RISPERDAL. RISPERDAL dosage: unknown. During the same period patient was treated with ENTUMIN, DIAZEPAM. Patient died on 02/18/2007.

Pharmacist from UNITED STATES reported RISPERDAL problem on Feb 20, 2007. Male patient, 79 years of age, was treated with RISPERDAL. After drug was administered, patient experienced the following problems/side effects: confusional state, lethargy. RISPERDAL dosage: unknown. During the same period patient was treated with REQUIP. Patient recovered.

Showing 1-75 of 1254 Next >

Ask Our Patient Community about RISPERDAL

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)